<--- Back to Details
First PageDocument Content
Melanoma / Genodermatoses / Tumor suppressor genes / Proteins / Carcinoma / Dysplastic nevus syndrome / Xeroderma pigmentosum / P16 / Ink4 / Medicine / Oncology / Biology
Date: 2015-02-25 08:39:40
Melanoma
Genodermatoses
Tumor suppressor genes
Proteins
Carcinoma
Dysplastic nevus syndrome
Xeroderma pigmentosum
P16
Ink4
Medicine
Oncology
Biology

CHAPTER 7 Inherited Tumour Syndromes The study of familial cancer syndromes has led to the discovery of key genes that are important not only for the understanding of the mechanismsm of genetic susceptibility but also fo

Add to Reading List

Source URL: www.iarc.fr

Download Document from Source Website

File Size: 1,87 MB

Share Document on Facebook

Similar Documents

Clinical Neutron Therapy System Reference Manual Jonathan Jacky1 Ruedi Risler Radiation Oncology, Box

Clinical Neutron Therapy System Reference Manual Jonathan Jacky1 Ruedi Risler Radiation Oncology, Box

DocID: 1xVse - View Document

Formal Development of a Graphical User Interface for a Radiation Therapy Machine Jonathan Jacky  Jonathan Unger Radiation Oncology Department RC-08 University of Washington

Formal Development of a Graphical User Interface for a Radiation Therapy Machine Jonathan Jacky  Jonathan Unger Radiation Oncology Department RC-08 University of Washington

DocID: 1xViy - View Document

Experience with Z Developing a Control Program for a Radiation Therapy Machine Jonathan Jacky , Jonathan Unger, Michael Patrick and Ruedi Risler Radiation Oncology Box

Experience with Z Developing a Control Program for a Radiation Therapy Machine Jonathan Jacky , Jonathan Unger, Michael Patrick and Ruedi Risler Radiation Oncology Box

DocID: 1xV2d - View Document

Formal Specication and Development of Control System Input/Output Jonathan Jacky Radiation Oncology Department RC-08 University of Washington

Formal Speci cation and Development of Control System Input/Output Jonathan Jacky Radiation Oncology Department RC-08 University of Washington

DocID: 1xUvZ - View Document

European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals

European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals

DocID: 1xTgE - View Document